AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Macsita-MXR 100/500 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Macsita-MXR 100/500 Tablet

Diabex-Duo 100/500mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex-Duo may be prescribed independently or in conjunction with other anti-diabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to your doctor's dietary and exercise plan is crucial for diabetes control; lifestyle significantly impacts management. Common side effects include nausea, diarrhea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, especially when used with insulin or sulfonylureas; learn its symptoms and management. This medication is not universally suitable. Inform your physician about prior kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating women should seek medical counsel. Interactions with other medications are possible; disclose all your medications for safety. Alcohol should be limited due to its potential to lower blood sugar. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Uses of Macsita-MXR 100/500 Tablet

Managing type 2 diabetes

Major Benefits of Macsita-MXR 100/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Macsita-MXR 100/500 Tablet should be administered with a meal.

Common Side effects of Macsita-MXR 100/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Macsita-MXR 100/500 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Macsita-MXR 100/500 Tablet with a meal.

How Macsita-MXR 100/500 Tablet works:

Macsita-MXR 100/500 tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and lessens the liver's glucose output. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Macsita-MXR 100/500 Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Macsita-MXR 100/500 tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Macsita-MXR 100/500 Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Macsita-MXR 100/500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. The use of Macsita-MXR 100/500 Tablets is contraindicated in individuals with severe kidney disease. Kidney function should be regularly monitored during treatment.

LiverLiverUNSAFE

The use of Macsita-MXR 100/500 Tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Macsita-MXR 100/500 Tablet :

Should you forget a Macsita-MXR 100/500 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Macsita-MXR 100/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Macsita-MXR 100/500 Tablet

Macsita-MXR 100/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is unsuitable for individuals under 18.
Prolonged use of Macsita-MXR 100/500 tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental state. To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Macsita-MXR 100/500 Tablet may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Macsita-MXR 100/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 100/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Macsita-MXR 100/500 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Macsita-MXR 100/500 tablets contain sitagliptin and metformin, treating type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Macsita-MXR 100/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Macsita-MXR 100/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 100/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Macsita-MXR 100/500 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-MXR 100/500 tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency can cause anemia and neurological issues, including tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Macsita-MXR 100/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Macsita-MXR 100/500 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Macsita-MXR 100/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 100/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Macsita-MXR 100/500 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-MXR 100/500 Tablet can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency can cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, as well as cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Macsita-MXR 100/500 Table...
134